while almost all patients experienced toxic reactions during the therapy , only 3 % -- 4 % of recipients of melphalan ( l-pam ; p ) and 4 % -- 5 % of recipients of l-pam + 5-fu ( f ) ( pf ) failed to complete 2 years of therapy because of toxicity .
C0025241
l-pam
C0279387
5